SureTrader
Home > Boards > US Listed > Medical - Drugs >

Merck & Co. Inc. (MRK)

MRK RSS Feed
Add MRK Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 4/23/2018 8:53:15 PM - Followers: 31 - Board type: Free - Posts Today: 0
SureTrader
MRK
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
MRK News: European Medicines Agency Validates Type II Variation for Merck’s KEYTRUDA® (pembrolizumab) in Combination with Pemetrexed... 04/23/2018 04:30:00 PM
MRK News: Statement of Changes in Beneficial Ownership (4) 04/17/2018 05:57:34 PM
MRK News: Initial Statement of Beneficial Ownership (3) 04/17/2018 05:56:40 PM
MRK News: Merck Announces First Phase Three Studies for PCV-15 (V114) Its Investigational Pneumococcal Disease Vaccine 04/17/2018 08:30:00 AM
MRK News: Merck’s KEYTRUDA® (pembrolizumab) Plus Pemetrexed (ALIMTA®) & Platinum Chemotherapy Reduced the Risk of Death by Half Com... 04/16/2018 09:30:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#363   BMY Bulls are throwing in the towel and chickpea598 04/23/18 08:53:15 PM
#362   Double upgrade on Lung Cancer drug! Buy! Buy! Buy! Paulsatsac 04/23/18 01:44:51 PM
#361   good to see, I agree. I didnt see dr_lowenstein 04/16/18 10:13:50 PM
#360   Merck regaining market confidence at AACR. NIce to chickpea598 04/16/18 08:18:04 PM
#359   MRK AACR-webcast slides: DewDiligence 04/16/18 08:11:05 PM
#358   OS HR=0.49 in KEYNOTE-189 overall trial: #msg-140072007. DewDiligence 04/16/18 11:32:57 AM
#357   MRK +6%; BMY -1% on Keytruda KEYNOTE-042 results: #msg-139894079. DewDiligence 04/09/18 12:01:58 PM
#356   INCY/MRK’s PR on phase-3 failure of Epacadostat as DewDiligence 04/06/18 09:44:44 AM
#355   MRK, Eisai ink global collaboration for Lenvima: #msg-139112383. DewDiligence 03/07/18 05:58:47 PM
#354   MRK’s PR on VLA.AX acquisition: DewDiligence 02/21/18 08:14:57 AM
#353   No updates of consequence to investors will be DewDiligence 02/16/18 02:44:10 AM
#352   How you you feel about this. Any more pennystockaholic 02/15/18 11:28:22 PM
#351   Verubecestat prodromal phase-3 stopped for futility: #msg-138524864. DewDiligence 02/13/18 07:23:09 PM
#349   MRK is driving up the DJIA past 26,000 crudeoil24 01/16/18 10:24:19 AM
#348   Gangbusters > solid FDA news: Merck's KEYTRUDA(R) (pembrolizumab) crudeoil24 01/16/18 10:09:36 AM
#347   Keytruda hits on OS/PFS in KEYNOTE-189: #msg-137706298. DewDiligence 01/16/18 09:31:53 AM
#346   Keytruda trial in second-line gastric cancer does not DewDiligence 12/14/17 06:14:19 PM
#345   Has moved above its one year target, but r clarke 12/06/17 04:41:33 PM
#344   FDA approves MRK’s Prevymis (letermovir) for prevention of DewDiligence 11/09/17 10:32:32 AM
#343   https://www.bloomberg.com/gadfly/amp/articles/2017-10-30/merck-delays-keytruda-c north40000 11/01/17 01:53:44 AM
#342   stock market Up %25... This year ..MRK down kubis 10/31/17 07:29:50 AM
#341   Transcript of MRK 3Q17 CC: DewDiligence 10/30/17 11:39:20 AM
#340   Stocks aren't linear but if you go back S60guy 10/30/17 06:25:12 AM
#339   check the chart, MRK was $93 a share shotgun 10/29/17 02:25:32 PM
#338   MRK withdraws EU application for Keytruda/chemo in first-line NSCLC: DewDiligence 10/27/17 04:47:54 PM
#337   MRK’s 3Q17 results: DewDiligence 10/27/17 01:21:11 PM
#336   CEO need go New management Because Stock market kubis 10/27/17 01:13:53 PM
#335   MRK’s US Zostavax sales at risk: #msg-135689292. DewDiligence 10/25/17 02:08:32 PM
#333   MRK formally dumps Anacetrapib program: #msg-135326811. DewDiligence 10/11/17 06:55:47 PM
#331   It is one thing to find yourself, or boroborough 10/10/17 10:14:00 AM
#330   FDA approves Keytruda in third-line gastric cancer for DewDiligence 09/22/17 04:17:14 PM
#329   MRK acquires private I-O company for €115M up-front DewDiligence 09/06/17 08:38:38 AM
#328   MRK market cap = 173.51B -- Uh yeah, MiguelHammond10 09/06/17 08:17:38 AM
#327   Anacetrapib CVOT shows very modest clinical benefit: #msg-134215022. DewDiligence 08/29/17 09:50:18 AM
#326   A new daily high at $62.73 was just MiguelHammond10 08/14/17 05:26:38 AM
#325   MRK 2Q17 CC (edited) transcript: DewDiligence 07/29/17 09:48:28 AM
#324   Will MRK buy KTOV after the recent amazing biotechnician 07/28/17 07:53:43 AM
#323   Renflexis FoB priced at 35% discount to (JNJ's) DewDiligence 07/24/17 11:03:42 AM
#322   Nice opportunity in SYN waiting on FDA approval MiguelHammond10 07/24/17 04:45:50 AM
#321   http://www.cnn.com/2017/07/19/health/gupta-mccain-glioblastoma/index.html north40000 07/20/17 12:28:26 AM
#320   NEWS TODAY: Merck's Keytruda in combo with KTOV biotechnician 07/18/17 01:19:18 PM
#319   Stalking The Institutional Trade Level ITMS 07/17/17 11:44:48 AM
#318   https://seekingalpha.com/article/4086073-merck-good-long-term-despite-major-setb Inoviorulez 07/06/17 12:27:42 PM
#317   FDA places clinical hold on Keytruda trials in DewDiligence 07/05/17 04:59:04 PM
#315   ASCO webcast slides: DewDiligence 06/05/17 06:48:54 PM
#314   FDA approves Keytruda for solid tumors with high DewDiligence 05/23/17 03:09:50 PM
#313   FDA approves two sBLAs for Keytruda in bladder cancer: DewDiligence 05/18/17 01:11:08 PM
#312   MRK—FDA approves Keytruda/chemo in first-line NSCLC regardless of DewDiligence 05/10/17 05:34:09 PM
#311   Transcript of MRK 1Q17 CC on 5/2/17: DewDiligence 05/09/17 10:28:00 AM
#310   MRK reports 1Q17 results—raises 2017 guidance: DewDiligence 05/02/17 08:13:35 AM
PostSubject